The GP2A is a member-led network of academic medicinal chemists working in universities and research institutes in Europe.
Founded in 1992, as the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A) by medicinal chemists working within Schools of Pharmacy near the western coast of Europe (the “Atlantic Arc”), it has rapidly expanded and currently includes academic members from France, Spain, Portugal, Ireland and the United Kingdom.
Our definition of medicinal chemistry is broad and membership is open to those working in areas as diverse as physical and pharmaceutical chemistry and molecular pharmacology as well as the traditional areas of natural product chemistry, pharmacognosy and drug discovery.
Our primary aim is networking to enable exchange of ideas and experience. This is facilitated through two major activities: Our annual scientific conference and PhD student and post-doctoral research exchanges.
The network provides bursaries to facilitate exchange between members’ laboratories.
This year’s conference, GP2A-JFB 2018, organised by members from the Universities of Caen and Rouen will take place between 13th and 15th June at Asnelles sur Mer (Normandie) and will feature invited lectures, oral communications and posters enabling researchers at all levels from PhD student to principle investigators to participate.
Exhibitors at the GP2A-JFB2018 meeting : Sponsors of the GP2A-JFB2018 meeting :
This year’s conference, GP2A-JFB 2018, organised by members from the Universities of Caen and Rouen will take place between 13th and 15th June at Asnelles sur Mer (Normandie). Final program schedule is available HERE !! Prizes will be given during the congress. – 2 Best Poster Awards sponsored by ManRos Therapeutics – 1 Best “PhDRead More…
– Dr Louisa Barré, CEA, University of Caen, France Rational development for a PET radiopharmaceutical probe – Dr Tatiana Besset, University of Rouen, France Combining organofluorine chemistry and C-H activation: New tools to fluorinated molecules – Prof. Maria Laura Bolognesi, University of Bologna, Italy Can theranostic small molecule combat neurodegenerative diseases? – Prof. Pascal Bonnet,Read More…